Workflow
冠状动脉棘突球囊扩张导管
icon
Search documents
公告精选丨嘉应制药:涉嫌信息披露违法违规遭中国证监会立案;ST联合:拟购买润田实业100%股份 5月29日复牌
Group 1 - Jia Ying Pharmaceutical is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, having received a notice of case filing on May 28, 2025 [2] - ST United plans to acquire 100% of Run Tian Industrial through a combination of share issuance and cash payment, with the stock set to resume trading on May 29 [3] - Long Gao Co., Ltd. is undergoing a restructuring of its controlling shareholder, Longyan Investment Development Group, which has established a new investment development group with a registered capital of 3 billion yuan [4] Group 2 - San You Chemical's controlling shareholder intends to inject 100 million yuan into its subsidiary, Tangshan San You Silicon Industry, through a private agreement [5] - ST Ji Pharmaceutical's stock will be delisted on May 29, 2025, due to a continuous closing price below 1 yuan for twenty trading days [6] - Hehe Information plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its global strategy and brand recognition [8] Group 3 - ST Huaxi has signed a significant contract worth approximately 2.9 billion USD (about 20.84 billion yuan) for a project in Iraq, which represents 80.38% of its latest audited revenue [9] - ST Longjin's stock will enter a delisting preparation period starting June 6, 2025, following a decision by the Shenzhen Stock Exchange [10] - Zhenbao Island's wholly-owned subsidiary intends to acquire a 49% stake in its controlling subsidiary, Guizhou Shennong Valley [11]
获批上市!乐普医疗冠脉棘突球囊扩张导管
思宇MedTech· 2025-04-08 15:27
报名:首届全球眼科大会 | 议程更新 报名:首届全球骨科大会 | 议程更新 报名:首届全球心血管大会 | 奖项申报 合作伙伴征集:2025全球手术机器人大会 心未来 近日, 乐普(北京)医疗器械股份有限公司 (以下简称 " 乐普医疗 ")研发的用于对狭窄血管病变预处 理的" Vessridge® 冠脉棘突球囊扩张导管 "(国械注准 20253030679 )正式获得国家药品监督管理局 ( NMPA )的上市批准。 值得一提的是,这是国产 第4款 冠状动脉棘突球囊扩张导管。 棘突球囊 以普通球囊导管为基础,使用尼龙切割件,截面为 类三角形突起物 ,固定于球囊两端,在球囊 充盈扩张时,借助凸出于球囊表面的尼龙切割件将压力聚焦传递给血管内壁,达到切割血管内膜、扩张狭 窄血管的目的,从而更有效扩张狭窄血管,有助于减少血管不规则撕裂、降低夹层发生风险。 因此,棘突球囊的出现改善了复杂病变预处理的效果,能够提高手术即刻成功率及远期预后。 | 国家约品监管管理局 National Medical Products Administration | 2 言数据查询 首页 政务服务门户 | | --- | --- | | 目境 ...